Saudi Arabia’s Dammam Valley takes control of German biotech firm Arcensus

 Saudi Arabia’s Dammam Valley takes control of German biotech firm Arcensus
Dammam Valley, an investment fund owned by the Imam Abdulrahman bin Faisal University in Saudi Arabia, has acquired a majority stake in direct-to-consumer clinical genetic testing startup Arcensus. Rostock, Germany-based Arcensus said that Dammam Valley and other undisclosed investors are making a “double-digit million euro” investment, without actually disclosing any […]
To read the rest of this article, you must be a subscriber. Click here to buy a subscription plan or Login here if you are already a subscriber.

Aman Malik

error: Content is protected !!
The Capital Quest